Abstract:ObjectiveTo evaluate the effect of this hyaluronan-supplemented transfer medium "EmbryoGlue®"(Vitrolife) on the implantation and pregnancy rate in a IVF-ET program.DesignA prospective, clinical study.Materials and methods92 women came for IVF treatment were enrolled from 2004 July to 2004 November. Two women were excluded from anlysis because both received blastocyst transfer. A total of 237 day 3 embryos were transferred. They are divided into the control group and the study group which used EmbryoGlue® as transfer media.ResultsThere were no differences in patients' age, duration of infertility, number of previous IVF attempts and the causes of infertility. The mean number of embryos transfer in the EmbryoGlue® group was 2.64 ± 1.28 vs. 2.62 ± 1.23 in the control group (P=0.92).The clinical pregnancy rate in the EmbryoGlue® group was 40% (18/45) vs. 53.3% (24/45) in the control group (P=0.16).The implantation rate was 31.1% (37/119) in the EmbryoGlue® group and 30.5% (36/118) in the control group (P=0.7).ConclusionOur data indicated that using EmbryoGlue® as transfer media was unlikely to significantly increase the implantation and clinical pregnancy rate in a day 3 ET program. Considering the high expression of receptors for hyaluronan on embryos at the expanded blastocyst stage, we suggest that EmbryoGlue® may work better on a day 5 embryo instead of a day 3 embryo. This hypothesis needs a further study to clarify the real benefit of using a hyaluronan-rich transfer medium like EmbryoGlue®. ObjectiveTo evaluate the effect of this hyaluronan-supplemented transfer medium "EmbryoGlue®"(Vitrolife) on the implantation and pregnancy rate in a IVF-ET program. To evaluate the effect of this hyaluronan-supplemented transfer medium "EmbryoGlue®"(Vitrolife) on the implantation and pregnancy rate in a IVF-ET program. DesignA prospective, clinical study. A prospective, clinical study. Materials and methods92 women came for IVF treatment were enrolled from 2004 July to 2004 November. Two women were excluded from anlysis because both received blastocyst transfer. A total of 237 day 3 embryos were transferred. They are divided into the control group and the study group which used EmbryoGlue® as transfer media. 92 women came for IVF treatment were enrolled from 2004 July to 2004 November. Two women were excluded from anlysis because both received blastocyst transfer. A total of 237 day 3 embryos were transferred. They are divided into the control group and the study group which used EmbryoGlue® as transfer media. ResultsThere were no differences in patients' age, duration of infertility, number of previous IVF attempts and the causes of infertility. The mean number of embryos transfer in the EmbryoGlue® group was 2.64 ± 1.28 vs. 2.62 ± 1.23 in the control group (P=0.92).The clinical pregnancy rate in the EmbryoGlue® group was 40% (18/45) vs. 53.3% (24/45) in the control group (P=0.16).The implantation rate was 31.1% (37/119) in the EmbryoGlue® group and 30.5% (36/118) in the control group (P=0.7). There were no differences in patients' age, duration of infertility, number of previous IVF attempts and the causes of infertility. The mean number of embryos transfer in the EmbryoGlue® group was 2.64 ± 1.28 vs. 2.62 ± 1.23 in the control group (P=0.92).The clinical pregnancy rate in the EmbryoGlue® group was 40% (18/45) vs. 53.3% (24/45) in the control group (P=0.16).The implantation rate was 31.1% (37/119) in the EmbryoGlue® group and 30.5% (36/118) in the control group (P=0.7). ConclusionOur data indicated that using EmbryoGlue® as transfer media was unlikely to significantly increase the implantation and clinical pregnancy rate in a day 3 ET program. Considering the high expression of receptors for hyaluronan on embryos at the expanded blastocyst stage, we suggest that EmbryoGlue® may work better on a day 5 embryo instead of a day 3 embryo. This hypothesis needs a further study to clarify the real benefit of using a hyaluronan-rich transfer medium like EmbryoGlue®. Our data indicated that using EmbryoGlue® as transfer media was unlikely to significantly increase the implantation and clinical pregnancy rate in a day 3 ET program. Considering the high expression of receptors for hyaluronan on embryos at the expanded blastocyst stage, we suggest that EmbryoGlue® may work better on a day 5 embryo instead of a day 3 embryo. This hypothesis needs a further study to clarify the real benefit of using a hyaluronan-rich transfer medium like EmbryoGlue®.

Influence of EmbryoGlue on the implantation of embryo and pregnancy outcome in vitro fertilization-embryo transfer]

Effect of EmbryoGlue® - A Hyaluronan-Supplemented Transfer Medium —on the Implantation and Pregnancy Rate in IVF Cycles

Effect of different transfer medium on clinical outcome of embryo transfer.

Influence of Cleavage-Stage Embryo Quality on the In-Vitro Fertilization Outcome after Single Embryo Transfer in Fresh Cycles.

Effect of Hyaluronic Acid-Enriched Media in Embryo Implantation

The effect of embryo transfer techniques on the clinical pregnancy rate of IVF.

The impact of the embryo transfer manipulation on the outcome of in vitro fertilization-embryo transfer

Application of the Established Method of Intrauterine Infusion of hCG before Embryo Transfer in IVF-ET and Mechanisms of hCG to Improve the Implantation and Pregnancy Rates

Clinical Outcomes of Different Embryo Transfer Strategies in IVF Treatment Cycles

Analysis of clinical outcomes for embryo transfer and blastocyst transfer

Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer Can Improve in Vitro Fertilization-Embryo Transfer Outcomes: a Meta-Analysis of Randomized Controlled Trials.

Abdominal Ultrasound-Guided Embryo Transfer Improves Clinical Pregnancy Rates After In Vitro Fertilization: Experiences from 330 Clinical Investigations

Factors influencing the outcomes of the vitrified frozen-thawed embryo transfer

Study on the impact of post-thawed culture of vitrified embryos on pregnancy outcomes

Modified super-long hormone replacement protocol improves pregnancy outcome of previously failed implantation patients undergoing frozen-thawed embryo transfer

Effect of Intrauterine Injection of Human Chorionic Gonadotropin Before Fresh Embryo Transfer on IVF and ICSI Outcomes: a Meta-Analysis

Influence of embryo culture medium on incidence of ectopic pregnancy in in vitro fertilization

Intrauterine Infusion of Human Chorionic Gonadotropin Before Embryo Transfer in IVF/ET Cycle: the Critical Review

Influence of zona pellucida Laser-thinning on embryo implantation in IVF-ET

How to improve the pregnancy outcome by optimizing embryo cryopreservation protocol

Influence of Incubation of Oocytes and Sperm for Different Period During IVF-ET on Pregnancy Outcome